For most people, the loss of a sense such as sight is devastating, not only for intensifying vulnerability, but for ...
TipRanks on MSN
Ultragenyx completes BLA filing for GSDIa gene therapy
Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...
Opinion
4dOpinion
AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities
GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...
There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.
Researchers studied 91 stress-response genes in a sweet potato relative, identifying potential roles in drought and disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback